The manufacturer Regen Biotech was established in 2000 and has been conducting national projects with government agencies such as the Ministry of Commerce, Industry and Energy and the Ministry of Health and Welfare of South Korea.
It’s a bio venture company that has commercialized products jointly developed with KIST (Korea Institute of Science and Technology) and leading domestic research institutes.
Regen Biotech is the first in the world to produce and sell PDLLA-made facial and body (buttocks and micropenis) fillers all over the world.
The brand AestheFill® is a compound word of Aesthetic and Dermal Filler, meaning filler with an artistic. sense. While general fillers focus on volume and anti-aging, AestheFill® goes one step further and creates natural volume to find the optimal point for the patient's face.
PowerFill® is a filler for the body made of next-generation material approved by the FDA. Instead of simply focusing on creating volume, PowerFill® provides a natural volume with a semi-permanent volume cycle. It is a filler that acts as a driving force to help patients lead a confident life.
02 Obtained CE approval
07 Completed registration in Chile for AestheFill and PowerFill
09 Obtained approval in Georgia
02 Obtained Korea Design Patent
10 AestheFill Taiwan Launch
12 Obtained AestheFill ANVISA approval in Brazil
03 Obtained Russia Trademark
05 Obtained Swiss, Germany, France, England, Ireland, Netherland, Spain, Italy, Turkey Patent: Biodegradable polymeric microparticles and their preparation method
12 Obtained Russia Trademark
03 For AestheFill and PowerFill, Thai FDA
distribution permit in Thailand obtained
03 Nico-N Clinical Test applied to KFDA
11 Obtained China Trademark
07 ISO 13485 Certification obtained
04 For AestheFill & PowerFill, KFDA manufacture license obtained
06 AestheFill Exclusive Distribution Contracts with partners in Singapore, Malaysia, Indonesia, Philippines, India, Vietnam and Russia.
09 AestheFill Exclusive Distribution Contracts with Senochem Biotech in China
12 For AestheFill & PowerFill, KFDA manufacture
09 Clinical Tests on AestheFill Completed at Asan Medical Center and Chung-ang Univeristy Hospital in Seoul
10 Clinical Tests on PowerFill Completed at Korea University Guro Hospital and Hallym University Medical Center in Seoul
01 Commercialized Birdie Shot, an Nico-N functional beverage to release hang-over, and an Nico-N candy
05 Completed Pre-clinical trials on MPLF for dermal tissues
06 Marketed ATONATURAL, a Moisturizer for Perfect Atopy Therapy
07 Developed 100% Atopy Natural Bioserum, BioCellulose Sheet Pack and Atopy Nutritional Supplement
08 The Third Phase of Original Technology Development Business in progress (R&D of Customized Porous Particles): Biocompatible, Biodegradable, Cell- attractable for Tissue Engineering & Regeneration, Sept. 2003 to Mar. 2011
11 Validity of our medical device certified by KGMP (Certification renewed)
07 Selected as the Medium-sized Venture of Technology Innovation by INNOBIZ
01 Negotiated with Japan, Thailand, Brazil, and India for export contracts and license sharing agreements on PowerPol
11 Validity of our medical device certified by Korea Good Manufacturing Practice (KGMP)
03 PowerPol approved by KFDA
09 REGEN project selected as the New Technology for Next Generation of the Ministry of Industry and Resources
07 REGEN project selected as the Venture of INNOBIZ by SMBA; Selected as the Co-Development of Core Technology Program of the former Ministry of Industry and Resources (current Ministry of Knowledge Economy)
10 The Best Venture Enterprise Award be conferred by the Special Committee on Medium Enterprises